Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  107 results for ""Zhang X""

Your Filters

Content Provider : MEDLINE Subject : prostatic neoplasms Filter by : Author
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

A mitochondrion-targeted cyanine agent for NIR-II fluorescence-guided surgery combined with intraoperative photothermal therapy to reduce prostate cancer recurrence.

  • Authors : Liu C; Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.; Institute of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/diagnostic imaging ; Photothermal Therapy*/Photothermal Therapy*/Photothermal Therapy*/methods ; Mitochondria*/Mitochondria*/Mitochondria*/metabolism

  • Source: Journal of nanobiotechnology [J Nanobiotechnology] 2024 May 03; Vol. 22 (1), pp. 224. Date of Electronic Publication: 2024 May 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101152208 Publication Model: Electronic Cited Medium: Internet ISSN: 1477-3155

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Real-world effectiveness and safety of goserelin 10.8-mg depot in Chinese patients with localized or locally advanced prostate cancer.

  • Authors : Chen N; Department of Urology, Meizhou People's Hospital, Meizhou 514089, China.; Wang Z

Subjects: Goserelin*/Goserelin*/Goserelin*/adverse effects ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy; Male

  • Source: Cancer biology & medicine [Cancer Biol Med] 2024 Feb 05; Vol. 20 (12).Publisher: Chinese Anti-Cancer Association Country of Publication: China NLM ID: 101588850 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Palmitic acid-activated GPRs/KLF7/CCL2 pathway is involved in the crosstalk between bone marrow adipocytes and prostate cancer.

  • Authors : Wang J; Shihezi University School of Medicine, Bei-Er-Lu, Shihezi, 832000, Xinjiang, China.; Laboratory of Xinjiang Endemic and Ethic Diseases, Shihezi University, Shihezi, 832000, Xinjiang, China.

Subjects: Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/pathology ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Animals

  • Source: BMC cancer [BMC Cancer] 2024 Jan 15; Vol. 24 (1), pp. 75. Date of Electronic Publication: 2024 Jan 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Chrysosplenol D can inhibit the growth of prostate cancer by inducing reactive oxygen species and autophagy.

  • Authors : Zhang H; Department of Urology, The Second People's Hospital of Kunshan, Kunshan, Jiangsu, China.; You Z

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Humans

  • Source: Immunity, inflammation and disease [Immun Inflamm Dis] 2023 Oct; Vol. 11 (10), pp. e1061.Publisher: John Wiley and Sons Ltd Country of Publication: England NLM ID: 101635460 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Development of [ 177 Lu]Lu-LNC1003 for radioligand therapy of prostate cancer with a moderate level of PSMA expression.

  • Authors : Wen X; State Key Laboratory of Molecular Vaccinology and Molecular, Diagnostics & Center for Molecular Imaging and Translational Medicine, School of PublicHealth, Xiamen University, 4221-116 Xiang'An South Rd, Xiamen, 361102, China.; Xu P

Subjects: Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/Glutamate Carboxypeptidase II*/metabolism ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/metabolism; Male

  • Source: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jul; Vol. 50 (9), pp. 2846-2860. Date of Electronic Publication: 2023 Apr 25.Publisher: Springer-Verlag Berlin Country of Publication: Germany NLM ID: 101140988 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Myeloid-like tumor hybrid cells in bone marrow promote progression of prostate cancer bone metastasis.

  • Authors : Ye X; School of Medicine, Southern University of Science and Technology, No. 1088 Xue Yuan Blvd, Shenzhen, 518055, Guangdong, China.; Huang X

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/metabolism; Humans

  • Source: Journal of hematology & oncology [J Hematol Oncol] 2023 May 03; Vol. 16 (1), pp. 46. Date of Electronic Publication: 2023 May 03.Publisher: Biomed Central Country of Publication: England NLM ID: 101468937 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-8722

Record details

Read Online Read More Add to Saved list
×
Academic Journal

miR-92a-1-5p enriched prostate cancer extracellular vesicles regulate osteoclast function via MAPK1 and FoxO1.

  • Authors : Yu L; Department of Laboratory Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China. .; Institute of Laboratory Medicine Center of Chinese People's Liberation Army (PLA), Xijing Hospital, Fourth Military Medical University (Air Force Medical University), , Xi'an, 710032, China. .

Subjects: Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/genetics ; Extracellular Vesicles*/Extracellular Vesicles*/Extracellular Vesicles*/metabolism ; MicroRNAs*/MicroRNAs*/MicroRNAs*/genetics

  • Source: Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 May 02; Vol. 42 (1), pp. 109. Date of Electronic Publication: 2023 May 02.Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Plasmacytoma variant translocation 1 inhibits miR-515-5p function and modulates high mobility group B3 to promote the growth of prostate cancer cells.

  • Authors : Zhu X; Department of Geriatrics, Renmin Hospital of Wuhan University, Wuhan, China.; Kang J

Subjects: MicroRNAs*/MicroRNAs*/MicroRNAs*/metabolism ; Plasmacytoma* ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/genetics

  • Source: Andrology [Andrology] 2023 May; Vol. 11 (4), pp. 641-650. Date of Electronic Publication: 2022 Sep 11.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101585129 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Safety, pharmacokinetics, and pharmacodynamics of SHR7280, an oral gonadotropin-releasing hormone receptor antagonist, in healthy men: a randomized, double-blind, placebo-controlled phase 1 study.

  • Authors : Li X; Phase I Clinical Research Center, The Affiliated Hospital of Qingdao University, 16 Jiangsu Road, Qingdao, 266003, China.; Sun F

Subjects: Gonadotropin-Releasing Hormone*/Gonadotropin-Releasing Hormone*/Gonadotropin-Releasing Hormone*/antagonists & inhibitors ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Receptors, LHRH*

  • Source: BMC medicine [BMC Med] 2023 Apr 03; Vol. 21 (1), pp. 129. Date of Electronic Publication: 2023 Apr 03.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer.

  • Authors : Han S; Department of Urology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No.17 Panjiayuan Nanli, Chaoyang District, Beijing, 100021, China.; Shi T

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology; Male

  • Source: Journal of translational medicine [J Transl Med] 2023 Mar 14; Vol. 21 (1), pp. 194. Date of Electronic Publication: 2023 Mar 14.Publisher: BioMed Central Country of Publication: England NLM ID: 101190741 Publication Model: Electronic Cited Medium: Internet ISSN: 1479-5876

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  107 results for ""Zhang X""